Table 4. Standardized Incidence Ratios for Cutaneous SCC in Cohort Studies of Organ Transplant Recipient.
Source | Transplantation Period | Country | Organ | Standardized Incidence Ratio | |
---|---|---|---|---|---|
First SCC | All SCCs | ||||
Birkeland et al, 1995 | 1964-1982 | Nordic countriesa | Kidney | 29.0/18.0b,c | NR |
Hartevelt et al, 1990 | 1966-1988 | The Netherlands | Kidney | NR | 253d |
Jensen et al, 1999 | 1963-1992 | Norway | Kidney, heart | 65 | NR |
Lindelöf et al, 2000 | 1970-1994 | Sweden | Solid organ | NR | 108.6/92.8c |
Adami et al, 2003 | 1970-1997 | Sweden | Solid organ | 56 | NR |
Moloney et al, 2006 | 1986-2001 | Ireland | Kidney | NR | 33.3b,e |
Aberg et al, 2008 | 1982-2005 | Finland | Liver | NR | 38.5b |
Jensen et al, 2010 | 1977-2006 | Denmark | Solid organ | NR | 82 |
Wisgerhof et al, 2011 | 1996-2006 | The Netherlands | Kidney | 39.6 | NR |
Harwood et al, 2013 | Up to 2006 | United Kingdom | Solid organ | NR | 153f |
Krynitz et al, 2013 | 1970-2008 | Sweden | Kidney | NR | 121 |
Heart, lung | 244 | ||||
Liver | 32 | ||||
Hortlund et al, 2017 | 1963-2011 | Sweden | Solid organ | 44.7 | NR |
1977-2011 | Denmark | 41.5 |
Abbreviations: NR, not reported; SCC, squamous cell carcinoma; SIR, standardized incidence ratio.
Denmark, Finland, Norway, and Sweden.
Nonmelanoma skin cancer.
Males/females.
With background population data from another region.
Followed up from 1994 through 2001.
Not calendar period-based.